World

Coach Kompany addresses Musiala's collapses due to treatment change

Bayern coach Vincent Kompany clarified that a change in Jamal Musiala's treatment led to his recent collapses on the field.

21 August 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Coach Kompany addresses Musiala's collapses due to treatment change — Archive photoPhoto: ManuluxWiki · Wikimedia Commons · CC BY-SA 4.0

Bayern Munich head coach Vincent Kompany provided an update regarding midfielder Jamal Musiala, who has experienced collapses during matches. Kompany stated that a slight change in Musiala's medication for a neurological disorder was the reason behind these incidents. He emphasized that this adjustment was the cause of the player's on-field collapses.

Musiala collapsed twice in a span of four days, raising concerns about his health. However, Kompany reassured fans and the media by stating that there is no cause for alarm regarding the player's condition. The coach expressed confidence that Musiala's health issues are manageable and will be addressed appropriately.

The team has been monitoring Musiala closely following these occurrences to ensure his well-being. According to reports, the adjustments made in his treatment are part of a broader strategy to manage his neurological dysfunction more effectively.

Kompany's comments aim to ease concerns among supporters and stakeholders who have been worried about the midfielder's fitness and safety during games. Bayern Munich continues to advocate for a careful approach to Musiala's treatment and overall health.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.